Sage Therapeutics Announces Third Quarter 2019 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Sage Therapeutics Announces Third Quarter 2019 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Misses Q3 EPS by 12c

November 12, 2019 6:35 AM EST

SAGE Therapeutics (NASDAQ: SAGE) reported Q3 EPS of ($3.48), $0.12 worse than the analyst estimate of ($3.36). Revenue for the quarter came in at $3.57 million versus the consensus estimate of $3.6 million.

Sages approach to drug discovery and development has led to the significant progress we have... More